Citigroup’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Citigroup’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,447	Closed	-$4K	–	7999
2019 Q4	$4K	Hold	4,447	–	–	﹤0.01%	7476
2019 Q3	$3K	Hold	4,447	–	–	﹤0.01%	7513
2019 Q2	$2K	Hold	4,447	–	–	﹤0.01%	7654
2019 Q1	$2K	Hold	4,447	–	–	﹤0.01%	7562
2018 Q4	$2K	Hold	4,447	–	–	﹤0.01%	7549
2018 Q3	$2K	Sell	4,447 -1,443,791	-100%	-$774K	﹤0.01%	7640
2018 Q2	$724K	Buy	1,448,238 +28	+0%	+$13	﹤0.01%	3704
2018 Q1	$612K	Sell	1,448,210 -106,223	-7%	-$42.7K	﹤0.01%	3784
2017 Q4	$591K	Buy	+1,554,433	New	+$590K	﹤0.01%	3936

Citigroup's GCVRZ Position: Q4 2017 in Review

Citigroup sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2017, closing a stake of 1,554,433 shares — an estimated $590K sold.

Citigroup first reported a position in GCVRZ in Q2 2013 and held it in 18 quarters. The position peaked at $1.23M in Q4 2014. 105 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2017.

Citigroup reported no remaining Sanofi Contingent Value Rights position as of Q4 2017 after selling out during the quarter.
Citigroup sold 1,554,433 Sanofi Contingent Value Rights shares in Q4 2017, an estimated $590K.
Citigroup first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 18 quarters.
Citigroup's Sanofi Contingent Value Rights position peaked at $1.23M in Q4 2014.
105 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2017.

Based on Citigroup's 13F filing for Q4 2017, filed 12 Feb 2018.